BPA Call 75F40120A00018-75F40121F19008
- This is a $61,852 firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Food and Drug Administration (FDA) to Westat, Inc., a for-profit professional services firm specializing in research, technical assistance, and evaluation services for federal agencies. The contract is for "QUICK TURNAROUND SOCIAL SCIENCE RESEARCH SERVICES" and does not have a set-aside designation. Westat has been awarded multiple indefinite delivery vehicles (IDVs) across the federal government,...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Food and Drug Administration (FDA) to Westat, Inc., a prominent professional services firm, for an experimental study related to front-of-pack food labeling. The contract has a ceiling value of $282,056.80 and a completion date of January 29, 2024. Westat, which is not a small business, holds several significant federal contract vehicles including a $999,999,999,999 OASIS+ Unrestricted Multiple Agency Contract with...
- This is a task order awarded by the Food and Drug Administration (FDA) to Westat, Inc., a prominent professional services firm in Rockville, Maryland. The task order was issued under the "Quick Turnaround Social Science Research Services" blanket purchase agreement (BPA), a $102,190 firm-fixed-price contract with a completion date of June 13, 2023. The contract does not have a set-aside designation. Westat has held several significant federal contract vehicles, including a...
- The Food and Drug Administration awarded a $447,205 firm fixed-price contract to Westat, Inc. under the AIMS GSA Schedule on September 7, 2018, with completion targeted for September 11, 2022. The award was issued as a BPA Call (Blanket Purchase Agreement call order) without a small business set-aside. The contract supports FDA's Quick Turnaround Social Science Research Services program and addresses research on endorser status and explicitness of payment in direct-to-consumer promotion—a...
- This is a firm fixed-price BPA call contract awarded by the Food and Drug Administration (FDA) to Westat, Inc., a prominent professional services firm, to conduct an experimental study on the effects of food labeling on consumer perceptions. The total ceiling value of the contract is $117,025.00, with a period of performance ending on June 27, 2026. The contract was awarded on September 17, 2020 and is not associated with a set-aside designation. Westat, Inc. is a for-profit organization...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call with the Food and Drug Administration (FDA) awarded to Westat, Inc., a professional services firm headquartered in Rockville, Maryland. The contract, valued at $595,931.00, is for a study on adverse event rates in direct-to-consumer prescription drug promotion. The award does not utilize a set-aside designation. Westat holds several significant federal contract vehicles, including a $999,999,999,999 OASIS+ Unrestricted Multiple...
- This is a firm fixed-price contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Westat, Inc., a prominent professional services firm, for focus group research on nutrition topics. The contract is a call under the Advertising & Integrated Marketing Solutions (AIMS) schedule of the General Services Administration (GSA). The contract has a ceiling value of $250,036.00 and a performance period through December 30, 2022. Westat has extensive experience providing...
- This is a firm fixed-price contract awarded by the Food and Drug Administration (FDA) to Westat, Inc., a professional services firm headquartered in Rockville, Maryland. The contract, valued at $699,513.00, is for services related to Limited English Proficiency and Consumer Processing of Direct-to-Consumer Prescription Drug Ad Elements. The contract does not have a set-aside designation and is a Blanket Purchase Agreement (BPA) Call. Westat, Inc. is a large for-profit organization that holds...
- This is a $85,413.18 firm fixed price Blanket Purchase Agreement (BPA) call awarded to Westat, Inc., a large for-profit research and professional services firm, by the Food and Drug Administration (FDA), a civilian agency. The contract is for "QUICK TURNAROUND SURVEYS" with a period of performance through May 1, 2026. There is no set-aside designation indicated. Westat has a substantial history of federal contract and grant awards across a range of domains including public health,...
- This federal contract award, valued at $480,469.00, was issued by the Food and Drug Administration (FDA) to the prime contractor Westat, Inc., a prominent professional services firm headquartered in Rockville, Maryland. The contract is a Blanket Purchase Agreement (BPA) call for a task order titled "Perceptions of Efficacy and Adherence in PDURs Products to be Awarded under Quick Turnaround Social Science Research Services BPA." The contract has a firm-fixed-price pricing type and an...
- Advertising & Integrated Marketing Solutions (AIMS)Master GSA Schedule
- GS23F0155K-75F40120A00018Blanket Purchase Agreement
- 75F40120A00018-75F40121F19008BPA Call
This is a firm fixed-price BPA call awarded by the Food and Drug Administration (FDA) to Westat, Inc., a prominent research and professional services firm, for a "Quantitative Terms and Phrases Study" under the GSA's AIMS (Advertising & Integrated Marketing Solutions) contract vehicle. The contract, valued at $399,533, has an ultimate completion date of August 1, 2025. Westat was selected for this study without a small business set-aside, indicating the company's strong capabilities and position as a major federal contractor. This contract is part of Westat's broader portfolio of research, technical assistance, and program support work across various government agencies, including the Centers for Disease Control and Prevention, National Cancer Institute, and Department of Agriculture, often executed through indefinite delivery vehicles (IDVs) and grants.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Other Administrative Action | $0 | 7/2/25 | |
| P00003 | Terminate for Convenience | $0 | 4/8/25 | |
| P00002 | Other Administrative Action | $0 | 6/23/23 | |
| P00001 | Other Administrative Action | $0 | 3/28/22 | |
| Not listed | Not listed | $399.5k | 7/21/21 |